Geode Capital Management
CLPT icon

Geode Capital Management’s ClearPoint Neuro CLPT Stock Holding History

Geode Capital Management’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.4M Buy
749,932
+44,212
+6% +$552K ﹤0.01% 2383
2026
Q1 		$6.42M Buy
705,720
+51,375
+8% +$649K ﹤0.01% 2621
2025
Q4 		$8.95M Sell
654,345
-2,052
-0.3% -$38K ﹤0.01% 2461
2025
Q3 		$14.3M Buy
656,397
+31,597
+5% +$372K ﹤0.01% 2196
2025
Q2 		$7.46M Buy
624,800
+323,429
+107% +$4.07M ﹤0.01% 2530
2025
Q1 		$3.58M Buy
301,371
+17,470
+6% +$272K ﹤0.01% 2822
2024
Q4 		$4.37M Sell
283,901
-3,393
-1% -$43.9K ﹤0.01% 2805
2024
Q3 		$3.22M Buy
287,294
+4,170
+1% +$39.9K ﹤0.01% 2959
2024
Q2 		$1.53M Sell
283,124
-229,909
-45% -$1.33M ﹤0.01% 3184
2024
Q1 		$3.49M Buy
513,033
+23,878
+5% +$167K ﹤0.01% 2881
2023
Q4 		$3.32M Buy
489,155
+35,156
+8% +$199K ﹤0.01% 2901
2023
Q3 		$2.27M Buy
453,999
+26,192
+6% +$156K ﹤0.01% 3030
2023
Q2 		$3.1M Buy
427,807
+205,334
+92% +$1.75M ﹤0.01% 2955
2023
Q1 		$1.88M Buy
222,473
+6,988
+3% +$61.2K ﹤0.01% 3060
2022
Q4 		$1.82M Buy
215,485
+327
+0.2% +$3.1K ﹤0.01% 3086
2022
Q3 		$2.23M Buy
215,158
+43,637
+25% +$575K ﹤0.01% 3045
2022
Q2 		$2.24M Sell
171,521
-144,185
-46% -$1.47M ﹤0.01% 3072
2022
Q1 		$3.29M Buy
315,706
+22,214
+8% +$202K ﹤0.01% 3015
2021
Q4 		$3.29M Buy
293,492
+1,656
+0.6% +$24.8K ﹤0.01% 3124
2021
Q3 		$5.18M Buy
291,836
+16,545
+6% +$310K ﹤0.01% 2895
2021
Q2 		$5.25M Buy
275,291
+159,353
+137% +$3.08M ﹤0.01% 2867
2021
Q1 		$2.45M Buy
115,938
+27,431
+31% +$587K ﹤0.01% 3159
2020
Q4 		$1.41M Buy
88,507
+69,639
+369% +$625K ﹤0.01% 3253
2020
Q3 		$103K Buy
18,868
+8,019
+74% +$35.4K ﹤0.01% 3898
2020
Q2 		$38K Hold
10,849
– – ﹤0.01% 4014
2020
Q1 		$38K Buy
+10,849
New +$53.3K ﹤0.01% 3966

Other funds holding CLPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
CFM
Compass Financial Management Tampa, Florida $829M AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Geode Capital Management's CLPT Position: Q2 2026 in Review

Geode Capital Management increased its ClearPoint Neuro (CLPT) stake by 6.3% in Q2 2026, buying an estimated $552K and bringing the position to 749,932 shares worth $13.4M. The position accounts for ﹤0.01% of the portfolio, ranked #2383.

Geode Capital Management first reported a position in CLPT in Q1 2020 and has held it in 26 quarters since. The position peaked at $14.3M in Q3 2025. 129 funds tracked by Wall St. Rank hold CLPT as of Q2 2026.

  • Geode Capital Management held 749,932 shares of ClearPoint Neuro worth $13.4M as of Q2 2026.
  • Geode Capital Management bought 44,212 ClearPoint Neuro shares in Q2 2026, an estimated $552K.
  • ClearPoint Neuro made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #2383 holding.
  • Geode Capital Management first reported a position in ClearPoint Neuro in Q1 2020 and has held it in 26 quarters since.
  • Geode Capital Management's ClearPoint Neuro position peaked at $14.3M in Q3 2025.
  • 129 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.